Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

(NASDAQ:COGT), WALTHAM, Mass. and BOULDER, Colo., Oct. 24, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced updated preclinical data from the company's potent and selective pan KRAS(ON) inhibitor in a poster presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular […]

Solowin Holdings Rings Nasdaq Opening Bell Under New Ticker “AXG”, Ushering in New Chapter of Digital Finance

Solowin Holdings Rings Nasdaq Opening Bell Under New Ticker “AXG”, Ushering in New Chapter of Digital Finance GlobeNewswire October 24, 2025 –Strategic Shift Focuses on Stablecoin Infrastructure and RWA Track Hong Kong, Oct. 24, 2025 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (NASDAQ: AXG) (“Solowin” or the “Company”), a leading financial services firm bridging traditional and digital

Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire October 24, 2025 WALTHAM, Mass. and BOULDER, Colo., Oct. 24, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced updated preclinical data

BlossomHill Therapeutics Presents Preliminary Findings from Phase 1/2 SOLARA Trial of BH-30643 in EGFR-mutant NSCLC at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

BlossomHill Therapeutics Presents Preliminary Findings from Phase 1/2 SOLARA Trial of BH-30643 in EGFR-mutant NSCLC at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics BH-30643, a first-in-class, macrocyclic OMNI-EGFR(TM) inhibitor, demonstrates preliminary anti-tumor activity across a variety of advanced EGFR-mutant non-small cell lung cancers with complex and difficult-to-treat resistance mutations GlobeNewswire October 24,

Lost Money on Baxter International, Inc. (BAX)? Contact Levi & Korsinsky Before December 15, 2025 to Join Class Action

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=173881&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Contact Levi & Korsinsky by November 3, 2025 to Join Class Action Against Tronox Holdings plc (TROX)

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=173880&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

COMPUCHILD Collaborates with Local Champions to Promote STEM Awareness Through NASA Space Apps Challenge

Children's After-School Education Franchise COMPUCHILD Helps Promote STEM-Focused Community Activity COMPUCHILD, a leading provider of Entrepreneurial STEAM™-focused after-school education programs for children, is pleased to announce the successful completion of the third annual NASA Space Apps Challenge™ local event at Mountain House, California. https://mma.prnewswire.com/media/2804830/CompuChild_and_Entrepreneur.jpg The NASA Space Apps Challenge is an international hackathon that unites

Levi & Korsinsky Notifies Savara Inc. (SVRA) Shareholders of Class Action Lawsuit and November 7, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=173878&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

/C O R R E C T I O N — Coupa Software/

In the news release, The Coupa Network Effect: Saving $14+ Billion Amidst Inflation and Trade Uncertainty, issued 23-Oct-2025 by Coupa Software over PR Newswire, we are advised by the company that there are minor changes to the text. The complete, corrected release follows: The Coupa Network Effect: Saving $14+ Billion Amidst Inflation and Trade Uncertainty

Levi & Korsinsky Investigates United Homes Group, Inc. (UHG) Over Possible Securities Fraud

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of United Homes Group, Inc. ("United Homes Group, Inc.") (NASDAQ:UHG) concerning possible violations of federal securities laws. On October 20, 2025, six UHG board members resigned following the refusal of Executive Chairman Michael

Scroll to Top